Encoded Therapeutics scores $135m Series D
South San Francisco-based Encoded Therapeutics, a precision gene therapy company, has raised $135 million in Series D financing.
22 July 2020•1 min read
South San Francisco-based Encoded Therapeutics, a precision gene therapy company, has raised $135 million in Series D financing.